Oral Liushen pill for patients with COVID‐19: A prospective randomized controlled trial

We examined the efficacy and safety of Liushen pill combined with basic treatment for patients with COVID‐19. In total, 181 patients hospitalized with COVID‐19, classified as asymptomatic mild type, were randomly divided into the experimental (n = 91) and control (n = 90) groups and were administere...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jianping, Liu, Yian, Lei, Wei, Shen, Junheng, Lu, Jing, Tao, Tao, Cao, Xu, Yang, Zhong, Huang, Jianan, Shi, Cuilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886519/
https://www.ncbi.nlm.nih.gov/pubmed/36733313
http://dx.doi.org/10.1002/pul2.12187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886519/
https://www.ncbi.nlm.nih.gov/pubmed/36733313
http://dx.doi.org/10.1002/pul2.12187

Ejemplares similares